Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GRN | P28799 | 1/20 | 0.33 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24499838 | 1.00 | KDM4E (0.33) | KDM4EGRNSORT1 | |
| SCHEMBL24499833 | 0.74 | APLNR (0.35) | — | |
| SCHEMBL16160076 | 0.71 | KDM4E (0.34) | KDM4EGRNSORT1 | |
| SCHEMBL30775677 | 0.70 | KDM4E (0.33) | KDM4EGRNSORT1 | |
| SCHEMBL278869 | 0.67 | KDM4E (0.34) | KDM4EGRNSORT1 | |
| SCHEMBL24499296 | 0.67 | CDK1 (0.35) | — | |
| SCHEMBL15907147 | 0.66 | KDM4E (0.33) | KDM4EGRNSORT1 | |
| SCHEMBL21718465 | 0.66 | GRN (0.33) | KDM4EGRNSORT1 | |
| SCHEMBL21718467 | 0.66 | KDM4E (0.33) | KDM4EGRNSORT1 | |
| SCHEMBL24899642 | 0.65 | APLNR (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220177470-A1 | SULFOXIMINE GLYCOSIDASE INHIBITORS | ASCENEURON SA (CH) | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220177470-A1 | SULFOXIMINE GLYCOSIDASE INHIBITORS | ENGASE, BACE1, GAA | KDM4E 2597/4885GRN 587/4885SORT1 420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.